County
Nash County Emergency Medical Services
Nash County Emergency Medical Services (NC) carries 40 drugs across 120 dose entries in its current published protocol, effective 2022-01-01.
The current listed document is more than 24 months old and may be outdated.
Drugs and doses40
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 325–1000 mg | PO | not captured | standing | page 24 |
| Fever | peds | 15 mg/kg | PO | not captured | standing | page 24 |
| Mild to moderate pain | adult | 325–1000 mg | PO | not captured | standing | page 25 |
| Mild to moderate pain | peds | 15 mg/kg | PO | not captured | standing | page 25 |
Activated Charcoal
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g/kg | PO | not captured | standing | page 152 |
| Other | peds | 1 g/kg | PO | not captured | standing | page 152 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 12 mg | IV/IO | not captured | standing | page 69 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 69 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | page 69 |
| Wide-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | page 71 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | page 75 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | page 75 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | page 131 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 324–650 mg | PO | not captured | standing | page 25 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | page 61 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 61 |
| Nerve agent exposure | adult | 2 mg | IM | not captured | standing | page 154 |
| Nerve agent exposure | peds | 0.5 mg | IM | not captured | standing | page 154 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 g | IV/IO | not captured | standing | page 152 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 1 g | IV/IO | not captured | standing | page 152 |
| Hyperkalemia | adult | 1 g | IV/IO | not captured | standing | page 91 |
| Hyperkalemia | peds | 1 g | IV/IO | not captured | standing | page 91 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 2 g | IV/IO | not captured | standing | page 152 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 1 g | IV/IO | not captured | standing | page 152 |
| Hyperkalemia | adult | 2 g | IV/IO | not captured | standing | page 91 |
| Hyperkalemia | peds | 1 g | IV/IO | not captured | standing | page 91 |
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 10 mg | IV/IO/IM | not captured | standing | page 95 |
| Adrenal crisis | peds | 10 mg | IV/IO/IM | not captured | standing | page 95 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 12.5 g | IV/IO | not captured | standing | page 89 |
| Hypoglycemia | peds | 5 mL/kg | IV/IO | not captured | standing | page 89 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2 mg | IV/IM/SQ | not captured | standing | page 164 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 0.25 mg/kg | IV/IO | not captured | standing | page 69 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 25–50 mg | PO | not captured | standing | page 87 |
| Anaphylaxis | adult | 25–50 mg | IV/IO/IM | not captured | standing | page 87 |
| Anaphylaxis | peds | 1 mg/kg | PO | not captured | standing | page 87 |
| Anaphylaxis | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 87 |
| Dystonic reaction | adult | 50 mg | IV/IO/IM/PO | not captured | standing | page 38 |
| Dystonic reaction | peds | 1 mg/kg | IV/IO/IM/PO | not captured | standing | page 38 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 2–20 mcg/kg | IV/IO | not captured | standing | page 61 |
| Hypotension / shock | adult | 5–20 mcg/kg | IV/IO | not captured | standing | page 139 |
| Hypotension / shock | peds | 5–20 mcg/kg | IV/IO | not captured | standing | page 139 |
Enalapril
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 1.25 mg | IV/IO | not captured | standing | page 67 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3–0.5 mg | IM | not captured | standing | page 47 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | page 47 |
| Bradycardia | adult | 1–10 mcg | IV/IO | not captured | standing | page 61 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 61 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 59 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 59 |
| Respiratory distress | peds | 1 mg | NEB | not captured | standing | page 47 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 50–100 mcg | IV/IO/IM | not captured | standing | page 25 |
| Severe pain | peds | 1 mcg/kg | IV/IO/IM | not captured | standing | page 25 |
| Post-intubation sedation | adult | 50–75 mcg | IV/IO | not captured | standing | page 55 |
| Post-intubation sedation | peds | 1 mcg/kg | IV/IO | not captured | standing | page 55 |
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 2–4 mg | IV/IO/IM | not captured | standing | page 152 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 152 |
| Hypoglycemia | peds | 0.1 mg/kg | IM | not captured | standing | page 89 |
Haloperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2 mg | IV/IM/SQ | not captured | standing | page 164 |
| Nausea / vomiting | adult | 2 mg | IV/IM/SQ | not captured | standing | page 164 |
Hydrocortisone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 100 mg | IV/IO/IM | not captured | standing | page 95 |
| Adrenal crisis | peds | 25 mg | IV/IO/IM | not captured | standing | page 95 |
Hydromorphone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 0.5 mg | IV/IM/SQ | not captured | standing | page 164 |
Ibuprofen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 400–600 mg | PO | not captured | standing | page 24 |
| Fever | peds | 10 mg/kg | PO | not captured | standing | page 24 |
| Mild to moderate pain | adult | 400–600 mg | PO | not captured | standing | page 25 |
| Mild to moderate pain | peds | 10 mg/kg | PO | not captured | standing | page 25 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Respiratory distress | adult | 0.5 mg | NEB | not captured | standing | page 47 |
| Respiratory distress | peds | 0.5 mg | NEB | not captured | standing | page 47 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Post-intubation sedation | adult | 1.5–2 mg/kg | IV/IO | not captured | standing | page 55 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 15 mg | IV/IO | not captured | standing | page 25 |
| Severe pain | adult | 30 mg | IM | not captured | standing | page 25 |
| Sepsis | adult | 15 mg | IV/IO/IM | not captured | standing | page 33 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Wide-complex tachycardia | adult | 1 mg/kg | IV/IO | not captured | standing | page 71 |
| VF / pulseless VT | adult | 1 mg/kg | IV/IO | not captured | standing | page 75 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 0.5 mg | IV/IM/SQ | not captured | standing | page 164 |
| Nausea / vomiting | adult | 0.5 mg | IV/IM/SQ | not captured | standing | page 164 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Respiratory distress | adult | 2 g | IV/IO | not captured | standing | page 47 |
| Respiratory distress | peds | 40 mg/kg | IV/IO | not captured | standing | page 47 |
| Wide-complex tachycardia | adult | 2 g | IV/IO | not captured | standing | page 73 |
| Wide-complex tachycardia | peds | 2 g | IV/IO | not captured | standing | page 73 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 125 mg | IV/IO | not captured | standing | page 87 |
| Anaphylaxis | peds | 2 mg/kg | IV/IO | not captured | standing | page 87 |
| Respiratory distress | adult | 125 mg | IV/IO/IM | not captured | standing | page 47 |
| Respiratory distress | peds | 2 mg/kg | IV/IO/IM | not captured | standing | page 47 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5 mg | IV/IO/IN | not captured | standing | page 40 |
| Agitation | peds | 0.1–0.2 mg/kg | IV/IO/IN | not captured | standing | page 40 |
| Hyperactive delirium | adult | 5 mg | IM | not captured | standing | page 41 |
| Hyperactive delirium | peds | 0.1–0.2 mg/kg | IM | not captured | standing | page 41 |
| Procedural sedation | adult | 2–2.5 mg | IV/IO/IM/IN | not captured | standing | page 15 |
| Procedural sedation | adult | 2.5 mg | IV/IO | not captured | standing | page 69 |
| Procedural sedation | peds | 0.1–0.2 mg/kg | IV/IO | not captured | standing | page 69 |
| Seizure | adult | 10 mg | IM | not captured | standing | page 29 |
| Seizure | adult | 2.5 mg | IV/IO | not captured | standing | page 29 |
| Seizure | peds | 0.2 mg/kg | IV/IO | not captured | standing | page 29 |
| Seizure | peds | 0.2 mg/kg | IM | not captured | standing | page 29 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 4 mg | IV/IO/IM | not captured | standing | page 25 |
| Severe pain | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 25 |
| Post-intubation sedation | adult | 4 mg | IV/IO | not captured | standing | page 55 |
| Post-intubation sedation | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 55 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.4–2 mg | IM/IN | not captured | standing | page 63 |
| Opioid overdose | adult | 0.4–2 mg | IV/IO/IM/IN/ET | not captured | standing | page 63 |
| Opioid overdose | peds | 0.1 mg/kg | IM/IN | not captured | standing | page 63 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO/IM/IN/ET | not captured | standing | page 63 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 65 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | page 67 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 1–10 mcg | IV/IO | not captured | standing | page 139 |
| Hypotension / shock | peds | 0.1–1 mcg/kg | IV/IO | not captured | standing | page 139 |
| Sepsis | adult | 1–10 mcg | IV/IO | not captured | standing | page 33 |
| Sepsis | peds | 0.1–1 mcg/kg | IV/IO | not captured | standing | page 33 |
Odansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV/IO/IM/ODT | not captured | standing | page 13 |
| Nausea / vomiting | peds | 0.2 mg/kg | IV/IO/IM/ODT | not captured | standing | page 13 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV/IM | not captured | standing | page 164 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | peds | 1/2 to 1 Tube | PO | not captured | standing | page 89 |
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 600 mg | IV/IO/IM | not captured | standing | page 154 |
| Nerve agent exposure | peds | 15–25 mg/kg | IV/IO/IM | not captured | standing | page 154 |
Promethazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 12.5 mg | IV/IO/IM | not captured | standing | page 13 |
| Nausea / vomiting | adult | 25 mg | IV/IM | not captured | standing | page 164 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 50 mEq | IV/IO | not captured | standing | page 91 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | page 91 |
| Tricyclic overdose | adult | 50 mEq | IV/IO | not captured | standing | page 152 |
| Tricyclic overdose | peds | 1 mEq/kg | IV/IO | not captured | standing | page 152 |